<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31959193</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-8118</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>21</Day></PubDate></JournalIssue><Title>Fluids and barriers of the CNS</Title><ISOAbbreviation>Fluids Barriers CNS</ISOAbbreviation></Journal><ArticleTitle>Non-invasive MRI quantification of cerebrospinal fluid dynamics in amyotrophic lateral sclerosis patients.</ArticleTitle><Pagination><StartPage>4</StartPage><MedlinePgn>4</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12987-019-0164-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Developing novel therapeutic agents to treat amyotrophic lateral sclerosis (ALS) has been difficult due to multifactorial pathophysiologic processes at work. Intrathecal drug administration shows promise due to close proximity of cerebrospinal fluid (CSF) to affected tissues. Development of effective intrathecal pharmaceuticals will rely on accurate models of how drugs are dispersed in the CSF. Therefore, a method to quantify these dynamics and a characterization of differences across disease states is needed.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Complete intrathecal 3D CSF geometry and CSF flow velocities at six axial locations in the spinal canal were collected by T2-weighted and phase-contrast MRI, respectively. Scans were completed for eight people with ALS and ten healthy controls. Manual segmentation of the spinal subarachnoid space was performed and coupled with an interpolated model of CSF flow within the spinal canal. Geometric and hydrodynamic parameters were then generated at 1&#xa0;mm slice intervals along the entire spine. Temporal analysis of the waveform spectral content and feature points was also completed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Comparison of ALS and control groups revealed a reduction in CSF flow magnitude and increased flow propagation velocities in the ALS cohort. Other differences in spectral harmonic content and geometric comparisons may support an overall decrease in intrathecal compliance in the ALS group. Notably, there was a high degree of variability between cases, with one ALS patient&#xa0;displaying nearly zero CSF flow along the entire spinal canal.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">While our sample size limits statistical confidence about the differences observed in this study, it was possible to measure and quantify inter-individual and cohort variability in a non-invasive manner. Our study also shows the potential for MRI based measurements of CSF geometry and flow to provide information about&#xa0; the hydrodynamic environment of the spinal subarachnoid space. These dynamics may be studied further to understand the behavior of CSF solute transport in healthy and diseased states.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sass</LastName><ForeName>Lucas R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Neurophysiological Imaging and Modeling Laboratory, University of Idaho, 875 Perimeter Dr. MS1122, Moscow, ID, 83844, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khani</LastName><ForeName>Mohammadreza</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurophysiological Imaging and Modeling Laboratory, University of Idaho, 875 Perimeter Dr. MS1122, Moscow, ID, 83844, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romm</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neurophysiological Imaging and Modeling Laboratory, University of Idaho, 875 Perimeter Dr. MS1122, Moscow, ID, 83844, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Washington School of Medicine, 1959 NE Pacific St, Seattle, WA, 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmid Daners</LastName><ForeName>Marianne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Product Development Group Zurich, Department of Mechanical and Process Engineering, ETH Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCain</LastName><ForeName>Kyle</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Neurophysiological Imaging and Modeling Laboratory, University of Idaho, 875 Perimeter Dr. MS1122, Moscow, ID, 83844, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freeman</LastName><ForeName>Tavara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Neurophysiological Imaging and Modeling Laboratory, University of Idaho, 875 Perimeter Dr. MS1122, Moscow, ID, 83844, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>Gregory T</ForeName><Initials>GT</Initials><AffiliationInfo><Affiliation>St. Luke's Rehabilitation Institute, 711 South Cowley St., Spokane, WA, 99202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weeks</LastName><ForeName>Douglas L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>St. Luke's Rehabilitation Institute, 711 South Cowley St., Spokane, WA, 99202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petersen</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Inland Imaging PS and LLC, 801 South Stevens St., Spokane, WA, 99204, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldred</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Selkirk Neurology, 610 South Sherman St. #201, Spokane, WA, 99202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wingett</LastName><ForeName>Dena</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Inland Imaging LLC, 801 South Stevens St., Spokane, WA, 99204, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Bryn A</ForeName><Initials>BA</Initials><Identifier Source="ORCID">0000-0003-1234-7880</Identifier><AffiliationInfo><Affiliation>Neurophysiological Imaging and Modeling Laboratory, University of Idaho, 875 Perimeter Dr. MS1122, Moscow, ID, 83844, USA. brynm@uidaho.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biological Engineering, University of Idaho, 875 Perimeter Dr. MS0904, Moscow, ID, 83844-0904, USA. brynm@uidaho.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P20 GM103408</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>4U54GM104944-04TBD</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R01NS111283-01</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R44MH112210-01A1</GrantID><Agency>The National Institutes of Mental Health</Agency><Country/></Grant><Grant><GrantID>P20GM1033408</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Fluids Barriers CNS</MedlineTA><NlmUniqueID>101553157</NlmUniqueID><ISSNLinking>2045-8118</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002555" MajorTopicYN="N">Cerebrospinal Fluid</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057446" MajorTopicYN="N">Hydrodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013115" MajorTopicYN="N">Spinal Canal</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013346" MajorTopicYN="N">Subarachnoid Space</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Cerebrospinal fluid</Keyword><Keyword MajorTopicYN="N">Intrathecal drug delivery</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Spinal cord</Keyword></KeywordList><CoiStatement>BAM has received grant support from Minnetronix Neuro, Alcyone Lifesciences, Voyager Therapeutics and Biogen. BAM is scientific advisory board member for Alcyone Lifesciences and the Chiari and Syringomyelia Foundation and has served as a consultant to SwanBio Therapeutics, Cerebral Therapeutics, Voyager Therapeutics, Cerevasc, Minnetronix, Medtrad Biosystems, Neurosyntek, and Behavior Imaging.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31959193</ArticleId><ArticleId IdType="pmc">PMC6971921</ArticleId><ArticleId IdType="doi">10.1186/s12987-019-0164-3</ArticleId><ArticleId IdType="pii">10.1186/s12987-019-0164-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schymick JC, Talbot K, Traynor BJ. Genetics of sporadic amyotrophic lateral sclerosis. Hum Mol Genet. 2007;16(Spec No. 2):R233&#x2013;R242. doi: 10.1093/hmg/ddm215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm215</ArticleId><ArticleId IdType="pubmed">17911166</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsultan AA, Waller R, Heath PR, Kirby J. The genetics of amyotrophic lateral sclerosis: current insights. Degener Neurol Neuromuscul Dis. 2016;6:49&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6053097</ArticleId><ArticleId IdType="pubmed">30050368</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread deconstructing motor neuron degeneration. Neurology. 2009;73(10):805&#x2013;811. doi: 10.1212/WNL.0b013e3181b6bbbd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181b6bbbd</ArticleId><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, Muravov O, Muravov K. Prevalence of amyotrophic lateral sclerosis&#x2014;United States, 2010&#x2013;2011. MMWR Suppl. 2014;63(7):1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">25054277</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7(6):557&#x2013;570. doi: 10.1016/j.genm.2010.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2010.11.010</ArticleId><ArticleId IdType="pubmed">21195356</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P, Robberecht W. Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery. Expert Opin Investig Drugs. 2014;23(7):955&#x2013;963. doi: 10.1517/13543784.2014.912275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/13543784.2014.912275</ArticleId><ArticleId IdType="pubmed">24816247</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilnak GJ, Charalambous LT, Cutshaw D, Premji AM, Giamberardino CD, Ballard CG, et al. Novel treatment of cryptococcal meningitis via neurapheresis therapy. J Infect Dis. 2018;218(7):1147&#x2013;1154. doi: 10.1093/infdis/jiy286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiy286</ArticleId><ArticleId IdType="pmc">PMC6107745</ArticleId><ArticleId IdType="pubmed">29788431</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackburn SL, Swisher CB, Grande AW, Rubi A, Verbick LZ, McCabe A, et al. Novel dual lumen catheter and filtration device for removal of subarachnoid hemorrhage: first case report. Oper Neurosurg. 2019;16(5):E148&#x2013;E153. doi: 10.1093/ons/opy151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ons/opy151</ArticleId><ArticleId IdType="pubmed">29873785</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J, Mamoli B. Liquorpheresis (CSF filtration) in familial amyotrophic lateral sclerosis. Spinal Cord. 1999;37(8):592&#x2013;593. doi: 10.1038/sj.sc.3100857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.sc.3100857</ArticleId><ArticleId IdType="pubmed">10455537</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J, Mamoli B. Cerebrospinal fluid filtration in amyotrophic lateral sclerosis. Eur J Neurol. 1999;6(5):597&#x2013;600. doi: 10.1046/j.1468-1331.1999.650597.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1468-1331.1999.650597.x</ArticleId><ArticleId IdType="pubmed">10457394</ArticleId></ArticleIdList></Reference><Reference><Citation>Khani M, Lawrence BJ, Sass LR, Gibbs CP, Pluid JJ, Oshinski JN, et al. Characterization of intrathecal cerebrospinal fluid geometry and dynamics in cynomolgus monkeys (Macaca fascicularis) by magnetic resonance imaging. PLoS ONE. 2019;14(2):e0212239. doi: 10.1371/journal.pone.0212239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0212239</ArticleId><ArticleId IdType="pmc">PMC6392269</ArticleId><ArticleId IdType="pubmed">30811449</ArticleId></ArticleIdList></Reference><Reference><Citation>Khani M, Xing T, Gibbs C, Oshinski JN, Stewart GR, Zeller JR, et al. Nonuniform moving boundary method for computational fluid dynamics simulation of intrathecal cerebrospinal flow distribution in a cynomolgus monkey. J Biomech Eng. 2017;139(8):081005. doi: 10.1115/1.4036608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1115/1.4036608</ArticleId><ArticleId IdType="pmc">PMC5467026</ArticleId><ArticleId IdType="pubmed">28462417</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangen KM, Hsu Y, Zhu DC, Linninger AA. CNS wide simulation of flow resistance and drug transport due to spinal microanatomy. J Biomech. 2015;48(10):2144&#x2013;2154. doi: 10.1016/j.jbiomech.2015.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbiomech.2015.02.018</ArticleId><ArticleId IdType="pubmed">25888012</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin BA, Kalata W, Shaffer N, Fischer P, Luciano M, Loth F. Hydrodynamic and longitudinal impedance analysis of cerebrospinal fluid dynamics at the craniovertebral junction in type I Chiari malformation. PLoS ONE. 2013;8(10):e75335. doi: 10.1371/journal.pone.0075335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0075335</ArticleId><ArticleId IdType="pmc">PMC3794956</ArticleId><ArticleId IdType="pubmed">24130704</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaffer N, Martin BA, Rocque B, Madura C, Wieben O, Iskandar BJ, et al. Cerebrospinal fluid flow impedance is elevated in type I Chiari malformation. J Biomech Eng Trans ASME. 2014;136(2):021012. doi: 10.1115/1.4026316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1115/1.4026316</ArticleId><ArticleId IdType="pmc">PMC4023655</ArticleId><ArticleId IdType="pubmed">24362680</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin BA, Yiallourou TI, Pahlavian SH, Thyagaraj S, Bunck AC, Loth F, et al. Inter-operator reliability of magnetic resonance image-based computational fluid dynamics prediction of cerebrospinal fluid motion in the cervical spine. Ann Biomed Eng. 2016;44(5):1524&#x2013;1537. doi: 10.1007/s10439-015-1449-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10439-015-1449-6</ArticleId><ArticleId IdType="pmc">PMC4824672</ArticleId><ArticleId IdType="pubmed">26446009</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd RA, Fletcher DF, Clarke EC, Bilston LE. Chiari malformation may increase perivascular cerebrospinal fluid flow into the spinal cord: a subject-specific computational modelling study. J Biomech. 2017;65:185&#x2013;193. doi: 10.1016/j.jbiomech.2017.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbiomech.2017.10.007</ArticleId><ArticleId IdType="pubmed">29096983</ArticleId></ArticleIdList></Reference><Reference><Citation>Linge SO, Haughton V, Lovgren AE, Mardal KA, Helgeland A, Langtangen HP. Effect of tonsillar herniation on cyclic CSF flow studied with computational flow analysis. Am J Neuroradiol. 2011;32(8):1474&#x2013;1481. doi: 10.3174/ajnr.A2496.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A2496</ArticleId><ArticleId IdType="pubmed">21596806</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke EC, Fletcher DF, Stoodley MA, Bilston LE. Computational fluid dynamics modelling of cerebrospinal fluid pressure in Chiari malformation and syringomyelia. J Biomech. 2013;46(11):1801&#x2013;1809. doi: 10.1016/j.jbiomech.2013.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbiomech.2013.05.013</ArticleId><ArticleId IdType="pubmed">23769174</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunck AC, Kroeger JR, Juettner A, Brentrup A, Fiedler B, Crelier GR, et al. Magnetic resonance 4D flow analysis of cerebrospinal fluid dynamics in Chiari I malformation with and without syringomyelia. Eur Radiol. 2012;22(9):1860&#x2013;1870. doi: 10.1007/s00330-012-2457-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-012-2457-7</ArticleId><ArticleId IdType="pubmed">22569996</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng S, Stoodley MA, Wong J, Hemley S, Fletcher DF, Bilston LE. The presence of arachnoiditis affects the characteristics of CSF flow in the spinal subarachnoid space: a modelling study. J Biomech. 2012;45(7):1186&#x2013;1191. doi: 10.1016/j.jbiomech.2012.01.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbiomech.2012.01.050</ArticleId><ArticleId IdType="pubmed">22386041</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowoslawska E, Gwizdala D, Baranska D, Grzelak P, Podgorski M, Zakrzewski K, et al. The oscillatory flow of the cerebrospinal fluid in the Sylvian aqueduct and the prepontine cistern measured with phase contrast MRI in children with hydrocephalus-a preliminary report. Childs Nerv Syst. 2018;34(5):845&#x2013;851. doi: 10.1007/s00381-017-3699-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00381-017-3699-0</ArticleId><ArticleId IdType="pmc">PMC5895674</ArticleId><ArticleId IdType="pubmed">29322338</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato K, Morimoto N, Matsuura T, Ohta Y, Tsunoda M, Ikeda Y, et al. CSF flow dynamics in motor neuron disease. Neurol Res. 2012;34(5):512&#x2013;517. doi: 10.1179/1743132812Y.0000000043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1743132812Y.0000000043</ArticleId><ArticleId IdType="pubmed">22664138</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin BA, Kalata W, Loth F, Royston TJ, Oshinski JN. Syringomyelia hydrodynamics: an in vitro study based on in vivo measurements. J Biomech Eng Trans ASME. 2005;127(7):1110&#x2013;1120. doi: 10.1115/1.2073687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1115/1.2073687</ArticleId><ArticleId IdType="pubmed">16502653</ArticleId></ArticleIdList></Reference><Reference><Citation>Sass LR, Khani M, Natividad GC, Tubbs RS, Baledent O, Martin BA. A 3D subject-specific model of the spinal subarachnoid space with anatomically realistic ventral and dorsal spinal cord nerve rootlets. Fluids Barriers CNS. 2017;14(1):36. doi: 10.1186/s12987-017-0085-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-017-0085-y</ArticleId><ArticleId IdType="pmc">PMC5738087</ArticleId><ArticleId IdType="pubmed">29258534</ArticleId></ArticleIdList></Reference><Reference><Citation>Khani M, Sass L, Xing T, Sharp MK, Bal&#xe9;dent O, Martin B. Anthropomorphic model of intrathecal cerebrospinal fluid dynamics within the spinal subarachnoid space: spinal cord nerve roots increase steady-streaming. J Biomech Eng. 2018;140(8):081012. doi: 10.1115/1.4040401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1115/1.4040401</ArticleId><ArticleId IdType="pmc">PMC6056198</ArticleId><ArticleId IdType="pubmed">30003260</ArticleId></ArticleIdList></Reference><Reference><Citation>Loth F, Yardimci MA, Alperin N. Hydrodynamic modeling of cerebrospinal fluid motion within the spinal cavity. J Biomech Eng. 2001;123(1):71&#x2013;79. doi: 10.1115/1.1336144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1115/1.1336144</ArticleId><ArticleId IdType="pubmed">11277305</ArticleId></ArticleIdList></Reference><Reference><Citation>Gehlen M, Kurtcuoglu V, Schmid Daners M. Is posture-related craniospinal compliance shift caused by jugular vein collapse? A theoretical analysis. Fluids Barriers CNS. 2017;14:5. doi: 10.1186/s12987-017-0053-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-017-0053-6</ArticleId><ArticleId IdType="pmc">PMC5314698</ArticleId><ArticleId IdType="pubmed">28209177</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin BA, Loth F, Kalata W, Oshinski JN, editors. MR measurement of pulse wave velocity in the spinal canal. In: Proceedings of the ASME summer bioengineering conference, SBC2008; 2009.</Citation></Reference><Reference><Citation>Yildiz S, Thyagaraj S, Jin N, Zhong X, Heidari Pahlavian S, Martin BA, et al. Quantifying the influence of respiration and cardiac pulsations on cerebrospinal fluid dynamics using real-time phase-contrast MRI. J Magn Reson Imaging. 2017;46(2):431&#x2013;439. doi: 10.1002/jmri.25591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.25591</ArticleId><ArticleId IdType="pubmed">28152239</ArticleId></ArticleIdList></Reference><Reference><Citation>Thyagaraj S, Pahlavian SH, Sass LR, Loth F, Vatani M, Choi JW, et al. An MRI-compatible hydrodynamic simulator of cerebrospinal fluid motion in the cervical spine. IEEE Trans Biomed Eng. 2017;65(7):1516&#x2013;1523. doi: 10.1109/TBME.2017.2756995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TBME.2017.2756995</ArticleId><ArticleId IdType="pmc">PMC6025821</ArticleId><ArticleId IdType="pubmed">28961100</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 2009;8(1):94&#x2013;109. doi: 10.1016/S1474-4422(08)70293-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70293-X</ArticleId><ArticleId IdType="pubmed">19081518</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie LL, Kang HY, Xu QW, Chen MJ, Liao YH, Thiyagarajan M, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373&#x2013;377. doi: 10.1126/science.1241224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1241224</ArticleId><ArticleId IdType="pmc">PMC3880190</ArticleId><ArticleId IdType="pubmed">24136970</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell J, Ding F, Nedergaard M. Distinct functional states of astrocytes during sleep and wakefulness: is norepinephrine the master regulator? Curr Sleep Med Rep. 2015;1(1):1&#x2013;8. doi: 10.1007/s40675-014-0004-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40675-014-0004-6</ArticleId><ArticleId IdType="pmc">PMC4659506</ArticleId><ArticleId IdType="pubmed">26618103</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringstad G, Vatnehol SAS, Eide PK. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain. 2017;140:2691&#x2013;2705. doi: 10.1093/brain/awx191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx191</ArticleId><ArticleId IdType="pmc">PMC5841149</ArticleId><ArticleId IdType="pubmed">28969373</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellano A, Papinutto N, Cadioli M, Brugnara G, Iadanza A, Scigliuolo G, et al. Quantitative MRI of the spinal cord and brain in adrenomyeloneuropathy: in vivo assessment of structural changes. Brain. 2016;139:1735&#x2013;1746. doi: 10.1093/brain/aww068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww068</ArticleId><ArticleId IdType="pubmed">27068048</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133&#x2013;150. doi: 10.1038/nrneurol.2017.188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2017.188</ArticleId><ArticleId IdType="pmc">PMC5829048</ArticleId><ArticleId IdType="pubmed">29377008</ArticleId></ArticleIdList></Reference><Reference><Citation>Kermode AG, Thompson AJ, Tofts P, Macmanus DG, Kendall BE, Kingsley DPE, et al. Breakdown of the blood-brain-barrier precedes symptoms and other MRI signs of new lesions in multiple-sclerosis&#x2014;pathogenetic and clinical implications. Brain. 1990;113:1477&#x2013;1489. doi: 10.1093/brain/113.5.1477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/113.5.1477</ArticleId><ArticleId IdType="pubmed">2245307</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mendili MM, Querin G, Bede P, Pradat PF. Spinal cord imaging in amyotrophic lateral sclerosis: historical concepts-novel techniques. Front Neurol. 2019;10:350. doi: 10.3389/fneur.2019.00350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00350</ArticleId><ArticleId IdType="pmc">PMC6474186</ArticleId><ArticleId IdType="pubmed">31031688</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquin ME, El Mendili MM, Gros C, Dupont SM, Cohen-Adad J, Pradat PF. Spinal cord gray matter atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol. 2018;39(1):184&#x2013;192. doi: 10.3174/ajnr.A5427.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5427</ArticleId><ArticleId IdType="pmc">PMC7410702</ArticleId><ArticleId IdType="pubmed">29122760</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mendili MM, Cohen-Adad J, Pelegrini-Issac M, Rossignol S, Morizot-Koutlidis R, Marchand-Pauvert V, et al. Multi-parametric spinal cord MRI as potential progression marker in amyotrophic lateral sclerosis. PLoS ONE. 2014;9(4):e95516. doi: 10.1371/journal.pone.0095516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095516</ArticleId><ArticleId IdType="pmc">PMC3995720</ArticleId><ArticleId IdType="pubmed">24755826</ArticleId></ArticleIdList></Reference><Reference><Citation>Branco LM, De Albuquerque M, De Andrade HM, Bergo FP, Nucci A, Franca MC., Jr Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(1&#x2013;2):93&#x2013;97. doi: 10.3109/21678421.2013.852589.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.852589</ArticleId><ArticleId IdType="pubmed">24219347</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Benatar M. Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis. Muscle Nerve. 2015;51(1):14&#x2013;18. doi: 10.1002/mus.24470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24470</ArticleId><ArticleId IdType="pmc">PMC4270289</ArticleId><ArticleId IdType="pubmed">25288265</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Chio A, Cosottini M, De Stefano N, Falini A, Mascalchi M, et al. The present and the future of neuroimaging in amyotrophic lateral sclerosis. Am J Neuroradiol. 2010;31(10):1769&#x2013;1777. doi: 10.3174/ajnr.A2043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A2043</ArticleId><ArticleId IdType="pubmed">20360339</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel SJ, Reddy CG, Frizon LA, Holland MT, Machado AG, Gillies GT, et al. Intrathecal therapeutics: device design, access methods, and complication mitigation. Neuromodulation. 2018;21(7):625&#x2013;640. doi: 10.1111/ner.12693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ner.12693</ArticleId><ArticleId IdType="pubmed">28961351</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadiq SA, Wang GC. Long-term intrathecal baclofen therapy in ambulatory patients with spasticity. J Neurol. 2006;253(5):563&#x2013;569. doi: 10.1007/s00415-005-0060-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-005-0060-4</ArticleId><ArticleId IdType="pubmed">16328111</ArticleId></ArticleIdList></Reference><Reference><Citation>McClelland S, 3rd, Bethoux FA, Boulis NM, Sutliff MH, Stough DK, Schwetz KM, et al. Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief. Muscle Nerve. 2008;37(3):396&#x2013;398. doi: 10.1002/mus.20900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20900</ArticleId><ArticleId IdType="pubmed">17894358</ArticleId></ArticleIdList></Reference><Reference><Citation>Saulino M, Ivanhoe CB, McGuire JR, Ridley B, Shilt JS, Boster AL. Best practices for intrathecal baclofen therapy: patient selection. Neuromodulation. 2016;19(6):607&#x2013;615. doi: 10.1111/ner.12447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ner.12447</ArticleId><ArticleId IdType="pubmed">27434197</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Karam C, Joyce N, Bedlack R, Carter GT. Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis. NeuroRehabilitation. 2015;37(1):53&#x2013;68. doi: 10.3233/NRE-151240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/NRE-151240</ArticleId><ArticleId IdType="pmc">PMC5223769</ArticleId><ArticleId IdType="pubmed">26409693</ArticleId></ArticleIdList></Reference><Reference><Citation>Dash RP, Babu RJ, Srinivas NR. Two decades-long journey from Riluzole to Edaravone: revisiting the clinical pharmacokinetics of the only two amyotrophic lateral sclerosis therapeutics. Clin Pharmacokinet. 2018;57(11):1385&#x2013;1398. doi: 10.1007/s40262-018-0655-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40262-018-0655-4</ArticleId><ArticleId IdType="pubmed">29682695</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez J, Federici T, Peterson B, Bartus R, Betourne A, Boulis NM. 321 Development of intrathecal riluzole: a new route of administration for the treatment of amyotrophic lateral sclerosis patients. Neurosurgery. 2016;63(CN_suppl_1):193. doi: 10.1227/01.neu.0000489810.52605.80.</Citation><ArticleIdList><ArticleId IdType="doi">10.1227/01.neu.0000489810.52605.80</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulis NM. Intrathecal riluzole for the treatment of patients with amyotrophic lateral sclerosis. Neurosurgery. 2019;66(Supplement_1):nyz310_818. doi: 10.1093/neuros/nyz310_818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuros/nyz310_818</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y, Kazuki Y, Kazuki K, Ebiki M, Nakanishi M, Nakamura K, et al. Use of a human artificial chromosome for delivering trophic factors in a rodent model of amyotrophic lateral sclerosis. Mol Ther Nucleic Acids. 2015;4:e253. doi: 10.1038/mtna.2015.28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mtna.2015.28</ArticleId><ArticleId IdType="pmc">PMC4881756</ArticleId><ArticleId IdType="pubmed">26440597</ArticleId></ArticleIdList></Reference><Reference><Citation>Deepa P, Shahani N, Alladi PA, Vijayalakshmi K, Sathyaprabha TN, Nalini A, et al. Down regulation of trophic factors in neonatal rat spinal cord after administration of cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients. J Neural Transm. 2011;118(4):531&#x2013;538. doi: 10.1007/s00702-010-0520-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-010-0520-6</ArticleId><ArticleId IdType="pubmed">21069391</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang DH, Lee HJ, Park IH, Seok JI, Kim BG, Joo IS, et al. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Ther. 2009;16(10):1234&#x2013;1244. doi: 10.1038/gt.2009.80.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gt.2009.80</ArticleId><ArticleId IdType="pubmed">19626053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr DA, Llado J, Shamblott MJ, Maragakis NJ, Irani DN, Crawford TO, et al. Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. J Neurosci. 2003;23(12):5131&#x2013;5140. doi: 10.1523/JNEUROSCI.23-12-05131.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-12-05131.2003</ArticleId><ArticleId IdType="pmc">PMC6741166</ArticleId><ArticleId IdType="pubmed">12832537</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindvall O, Kokaia Z. Stem cells in human neurodegenerative disorders&#x2013;time for clinical translation? J Clin Invest. 2010;120(1):29&#x2013;40. doi: 10.1172/JCI40543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI40543</ArticleId><ArticleId IdType="pmc">PMC2798697</ArticleId><ArticleId IdType="pubmed">20051634</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, Beers DR, Zhao W, Appel SH. Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol. 2009;4(4):389&#x2013;398. doi: 10.1007/s11481-009-9171-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-009-9171-5</ArticleId><ArticleId IdType="pubmed">19731042</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw PJ. Toxicity of CSF in motor neurone disease: a potential route to neuroprotection. Brain. 2002;125:693&#x2013;694. doi: 10.1093/brain/awf138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awf138</ArticleId><ArticleId IdType="pubmed">11912105</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockman HW. Effect of anatomical fine structure on the dispersion of solutes in the spinal subarachnoid space. J Biomech Eng. 2007;129(5):666&#x2013;675. doi: 10.1115/1.2768112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1115/1.2768112</ArticleId><ArticleId IdType="pubmed">17887892</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuttler A, Dimke T, Kern S, Helmlinger G, Stanski D, Finelli LA. Understanding pharmacokinetics using realistic computational models of fluid dynamics: biosimulation of drug distribution within the CSF space for intrathecal drugs. J Pharmacokinet Pharmacodyn. 2010;37(6):629&#x2013;644. doi: 10.1007/s10928-010-9184-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10928-010-9184-y</ArticleId><ArticleId IdType="pmc">PMC3005107</ArticleId><ArticleId IdType="pubmed">21132572</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu Y, Hettiarachchi HD, Zhu DC, Linninger AA. The frequency and magnitude of cerebrospinal fluid pulsations influence intrathecal drug distribution: key factors for interpatient variability. Anesth Analg. 2012;115(2):386&#x2013;394. doi: 10.1213/ANE.0b013e3182536211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e3182536211</ArticleId><ArticleId IdType="pubmed">22523420</ArticleId></ArticleIdList></Reference><Reference><Citation>Hettiarachchi HDM, Hsu Y, Harris TJ, Linninger AA. The effect of pulsatile flow on intrathecal drug delivery in the spinal canal. Ann Biomed Eng. 2011;39(10):2592&#x2013;2602. doi: 10.1007/s10439-011-0346-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10439-011-0346-x</ArticleId><ArticleId IdType="pubmed">21751071</ArticleId></ArticleIdList></Reference><Reference><Citation>Keith Sharp M, Carare RO, Martin BA. Dispersion in porous media in oscillatory flow between flat plates: applications to intrathecal, periarterial and paraarterial solute transport in the central nervous system. Fluids Barriers CNS. 2019;16(1):13. doi: 10.1186/s12987-019-0132-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-019-0132-y</ArticleId><ArticleId IdType="pmc">PMC6512764</ArticleId><ArticleId IdType="pubmed">31056079</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>